Department of Hematology & Oncology, Medical Center, University of Tuebingen, Tuebingen, Germany.
Leukemia. 2011 Jan;25(1):121-9. doi: 10.1038/leu.2010.235. Epub 2010 Oct 14.
Haploidentical hematopoietic cell transplantation (HHCT) using CD34 selected grafts is complicated by slow engraftment and immune reconstitution. Engraftment and immune reconstitution might be improved using CD3/CD19-depleted grafts and reduced intensity conditioning (RIC). We report on 28 patients after HHCT with CD3/CD19-depleted grafts using RIC, which were prospectively evaluated for engraftment and immune reconstitution. Engraftment was rapid with full chimerism reached on day +15 after HHCT. T-cell reconstitution was delayed with a median of 205 CD3+ cells/μl, 70 CD3+CD4+ cells/μl and 66 CD3+ CD8+ cells/μl on day +100, respectively. A skewed T-cell receptor-Vβ repertoire with oligoclonal T-cell expansions to day +100 and normalization after day +200 was observed. B-cell reconstitution was slow with a median of 100 CD19+ CD20+ cells/μl on day +150. Natural killer (NK) cell engraftment was fast reaching normal values on day +20. An increased natural cytotoxicity receptor and NKG2A, but decreased NKG2D and KIR expressions were observed on NK cells until day +100. We observed a positive impact of donor lymphocyte infusions on immune reconstitution. In conclusion, after HHCT, using CD3/CD19-depleted grafts and RIC, T- and B-cell reconstitution is delayed, whereas NK-cell reconstitution occurs early and fast.
采用 CD34 分选移植物的单倍体造血细胞移植(HHCT)会导致植入延迟和免疫重建缓慢。使用 CD3/CD19 耗竭移植物和降低强度的调理(RIC)可以改善植入和免疫重建。我们报告了 28 例接受 CD3/CD19 耗竭移植物和 RIC 的 HHCT 患者,前瞻性评估了他们的植入和免疫重建情况。移植快速,HHCT 后第 15 天达到完全嵌合。T 细胞重建延迟,中位数为第 100 天 205 个/μl、70 个/μl CD3+CD4+细胞和 66 个/μl CD3+CD8+细胞。观察到 T 细胞受体-Vβ 库的偏斜,存在到第 100 天的寡克隆 T 细胞扩增,并在第 200 天后恢复正常。B 细胞重建缓慢,中位数为第 150 天 100 个/μl CD19+CD20+细胞。NK 细胞植入快速,第 20 天达到正常值。在 NK 细胞中观察到自然细胞毒性受体和 NKG2A 的表达增加,而 NKG2D 和 KIR 的表达减少,直到第 100 天。我们观察到供者淋巴细胞输注对免疫重建有积极影响。总之,在 HHCT 后,使用 CD3/CD19 耗竭移植物和 RIC,T 细胞和 B 细胞重建延迟,而 NK 细胞重建发生早且快速。